CATALYST PHARMACEUTICALS, INC. (CPRX)
Pharmaceutical Preparations · Healthcare · $3.8B
Intrinsic Value (Consensus)
$36.79
Current Price
$31.40
Margin of Safety
+17.2%
17.2% Below Intrinsic Value
Value: $37
Price: $31
Valuation Model Estimates
Current Price: $31.40
DCF (Discounted Cash Flow)
$80.07
Graham Number
$17.18
Earnings Power Value
$16.31
Relative Value (P/E)
$33.60
Dividend Discount Model
Not applicable
—
Consensus Value
$36.79
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
77
Profitability
22/25
Strength
17/25
Valuation
19/25
Growth
19/25
Financial Health Signals
Strong profitability — ROE of 22% (above 20% is excellent)
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $1.68
- EPS (Forward)
- $2.02
- Book Value
- $7.81
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 22.5%
- Debt/Equity
- —
- Revenue Growth
- 19.8%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance